Jan Philipp Bewersdorf

Author

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

Aaron D. Goldberg, Bewersdorf, J.P., Bewersdorf, Jan Philipp, Heaney, Mark L, Jan Bewersdorf, Jan P Bewersdorf, Jan P. Bewersdorf, Jan Philipp Bewersdorf, Jan Philipp Philipp Bewersdorf, Jan Phillipp Bewersdorf

261

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Yale University Yale Cancer Center Dana-Farber Cancer Institute Cornell University

About

Jan Philipp Bewersdorf is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	655
2	Health Sciences	4	4	195
3	Cell Biology	4	4	180
4	Public Health	1	1	12
5	Blood Transplantation	1	1	42

Jan Philipp Bewersdorf

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study Maximilian Stahl, Rory M. Shallis, Wei Wei, Leukemia Hematological MalignancyMedicineAcute Myeloid LeukemiaLong-term Clinical OutcomesHematology	2020	90
Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States Amer M. Zeidan, Rong Wang, Xiaoyi Wang, Blood Advances	2020	87
Consensus proposal for revised International Working Group response criteria for higher risk myelodysplastic syndromes Amer M. Zeidan, Uwe Platzbecker, Jan Philipp Bewersdorf, Blood	2023	87
Calcium Influx through Plasma-Membrane Nanoruptures Drives Axon Degeneration in a Model of Multiple Sclerosis Maarten E. Witte, Adrian-Minh Schumacher, Christoph Mahler, Neuron	2019	86
Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes Amer M. Zeidan, Daniel J. DeAngelo, Jeanne Palmer, Annals of Hematology Hematological MalignancyMedicineHematologyImmunologyHigh-risk Myelodysplastic Syndromes	2022	84
Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells Khrystyna North, Salima Benbarche, Bo Liu, Nature Biotechnology Rna ProcessingMedicineCancer Cell BiologyCancer GenomicsCancer Genetics	2022	59
Vascular Endothelial Growth Factor: A Novel Endocrine Defensive Response to Hypoglycemia Dorle Dantz, Jan Philipp Bewersdorf, Bernd Fruehwald‐Schultes, The Journal of Clinical Endocrinology & Metabolism ImmunologyVegf ConcentrationInsulin SignalingOxidative StressCerebral Vascular Regulation	2002	55
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND) Talha Badar, Ehab Atallah, Rory M. Shallis, Leukemia Hematological MalignancyNeoplastic DiseasesTransplantationMarrow TransplantationMedicine	2023	53
Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States Amer M. Zeidan, Nikolai A. Podoltsev, Xiaoyi Wang, Blood Advances	2020	51
Challenges in HSV encephalitis: normocellular CSF, unremarkable CCT, and atypical MRI findings Jan Philipp Bewersdorf, Uwe Koedel, Maximilian Patzig, Infection Normocellular CsfUnremarkable CctNeurovirologyMedicineHsv Encephalitis	2018	46

Page 1